In humans, Cactin (C19ORF29) was originally described as a renal carcinoma antigen (Scanlan et al. 1999) and more recently as a negative regulator of Toll-like receptor and innate immune signaling (Atzei et al. 2010). The gene discussed is CACTIN; the disease is renal carcinoma.